Know Labs is developing a device that uses radiofrequency waves and artificial intelligence to interrogate and measure blood glucose levels in patients.
“Each and every molecule/analyte possesses a unique frequency at which it ‘excites’ or ‘resonates,’” Know Labs’ CEO Ron Erickson explained...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?